Cardio-Renal-Metabolic Drugs Face World Made By GLP-1s, Juiced By National Priority Vouchers

 
• By Bridget Silverman
  
New entries could emerge in the hypertension market in 2026. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pink Sheet Perspectives

More from Pink Sheet